• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

法布瑞病患者血清 TWEAK 水平与颈动脉内膜中层厚度的关系。

The Relationship between Serum TWEAK Levels and Carotid Intima-media Thickness in Patients with Fabry Disease.

机构信息

Department of Internal Medicine, Division of Nephrology, Meram School of Medicine, Necmettin Erbakan University, Konya, Turkey.

Department of Internal Medicine, Division of Internal Medicine, Meram School of Medicine, Necmettin Erbakan University, Konya, Turkey.

出版信息

Saudi J Kidney Dis Transpl. 2023 Sep 1;34(5):406-415. doi: 10.4103/1319-2442.397202. Epub 2024 Mar 11.

DOI:10.4103/1319-2442.397202
PMID:38995299
Abstract

Fabry disease (FD) is associated with inflammation, proteinuria, and chronic kidney disease. Tumor necrosis factor-like weak inducer of apoptosis (TWEAK) plays an important role in inflammation in diabetic nephropathy and lupus nephritis. Since there is a close relationship linking serum TWEAK (sTWEAK), inflammation, and carotid intima-media thickness (CIMT) in various kidney diseases, we aimed to determine the relationship between sTWEAK levels and CIMT in subjects with and without proteinuria in a cross-sectional study involving 15 FD patients (seven females, eight males) and seven healthy controls (four females, three males). There were no differences in age, sex, estimated glomerular filtration rate, and biochemical parameters (serum glucose, albumin, creatinine, uric acid, C-reactive protein (CRP), low-density lipoprotein, and high-density lipoprotein) between FD patients and healthy controls. The spot urine protein-creatinine ratios of healthy controls and FD patients were 90 mg/g and 185 mg/g, respectively (P = 0.022). STWEAK levels were higher in FD patients than in healthy controls (P = 0.007). The CIMT of FD patients and healthy controls was 0.55 ± 0.14 mm and 0.42 ± 0.04 mm, respectively (P = 0.007). STWEAK was positively correlated with CRP and CIMT, and negatively with proteinuria (P = 0.005, P = 0.013, and P = 0.018, respectively). In the multivariate analysis, only sTWEAK was an independent variable of increased CIMT. We demonstrated that sTWEAK and CIMT were increased in FD patients. STWEAK might have a role in the pathogenesis of subclinical atherosclerosis in FD.

摘要

法布里病(FD)与炎症、蛋白尿和慢性肾脏病有关。肿瘤坏死因子样凋亡弱诱导物(TWEAK)在糖尿病肾病和狼疮性肾炎的炎症中发挥重要作用。由于血清 TWEAK(sTWEAK)、炎症和颈动脉内膜中层厚度(CIMT)在各种肾脏疾病之间存在密切关系,我们旨在确定在一项横断面研究中,有无蛋白尿的 FD 患者(7 名女性,8 名男性)和 7 名健康对照者(4 名女性,3 名男性)之间 sTWEAK 水平与 CIMT 的关系。FD 患者和健康对照组之间的年龄、性别、估计肾小球滤过率和生化参数(血清葡萄糖、白蛋白、肌酐、尿酸、C 反应蛋白(CRP)、低密度脂蛋白和高密度脂蛋白)无差异。健康对照者和 FD 患者的尿蛋白/肌酐比值分别为 90mg/g 和 185mg/g(P=0.022)。FD 患者的 sTWEAK 水平高于健康对照组(P=0.007)。FD 患者和健康对照组的 CIMT 分别为 0.55±0.14mm 和 0.42±0.04mm(P=0.007)。sTWEAK 与 CRP 和 CIMT 呈正相关,与蛋白尿呈负相关(P=0.005,P=0.013,P=0.018)。在多元分析中,只有 sTWEAK 是 CIMT 增加的独立变量。我们证明 FD 患者的 sTWEAK 和 CIMT 增加。sTWEAK 可能在 FD 的亚临床动脉粥样硬化发病机制中起作用。

相似文献

1
The Relationship between Serum TWEAK Levels and Carotid Intima-media Thickness in Patients with Fabry Disease.法布瑞病患者血清 TWEAK 水平与颈动脉内膜中层厚度的关系。
Saudi J Kidney Dis Transpl. 2023 Sep 1;34(5):406-415. doi: 10.4103/1319-2442.397202. Epub 2024 Mar 11.
2
Soluble TWEAK independently predicts atherosclerosis in renal transplant patients.可溶性 TWEAK 可独立预测肾移植患者的动脉粥样硬化。
BMC Nephrol. 2013 Jul 12;14:144. doi: 10.1186/1471-2369-14-144.
3
Soluble Tumor Necrosis Factor (TNF)-Like Weak Inducer of Apoptosis (Tweak) Independently Predicts Subclinical Atherosclerosis in Behcet's Disease.可溶性肿瘤坏死因子(TNF)样凋亡微弱诱导剂(Tweak)独立预测白塞病的亚临床动脉粥样硬化。
Acta Medica (Hradec Kralove). 2018;61(3):86-92. doi: 10.14712/18059694.2018.123.
4
Soluble TWEAK may predict carotid atherosclerosis in treated HIV infection.可溶性肿瘤坏死因子样弱凋亡诱导因子(TWEAK)可能预测接受治疗的HIV感染患者的颈动脉粥样硬化。
HIV Clin Trials. 2017 Jul;18(4):156-163. doi: 10.1080/15284336.2017.1366001. Epub 2017 Aug 22.
5
Inverse Relationship between Plasma Tumor Necrosis Factor-Like Weak Inducer of Apoptosis and Carotid Intima-Media Thickness among Patients Undergoing Hemodialysis and Peritoneal Dialysis.血液透析和腹膜透析患者血浆肿瘤坏死因子样弱凋亡诱导剂与颈动脉内膜中层厚度的反比关系。
Cardiorenal Med. 2020;10(3):137-144. doi: 10.1159/000503811. Epub 2020 Mar 3.
6
The relationship between asymptomatic organ damage, and serum soluble tumor necrosis factor-like weak inducer of apoptosis (sTWEAK) and Interleukin-17A (IL-17A) levels in non-diabetic hypertensive patients.非糖尿病高血压患者无症状器官损伤与血清可溶性肿瘤坏死因子样凋亡弱诱导剂(sTWEAK)及白细胞介素-17A(IL-17A)水平之间的关系。
BMC Nephrol. 2014 Oct 1;15:159. doi: 10.1186/1471-2369-15-159.
7
Changes in Soluble TWEAK Concentrations, but Not Those in Amyloid-β(1-40), Are Associated with a Decrease in Carotid Intima-Media Thickness after Bariatric Surgery in Obese Women.肥胖女性减重手术后可溶性 TWEAK 浓度变化与颈动脉内膜中层厚度下降有关,而淀粉样β(1-40)浓度变化与颈动脉内膜中层厚度下降无关。
Obes Facts. 2020;13(3):321-330. doi: 10.1159/000507087. Epub 2020 May 8.
8
Clinical significance of serum interleukin-8 and soluble tumor necrosis factor-like weak inducer of apoptosis levels in patients with diabetic nephropathy.血清白细胞介素-8 和可溶性肿瘤坏死因子样弱凋亡诱导因子水平与糖尿病肾病患者的临床意义。
J Diabetes Investig. 2018 Sep;9(5):1182-1188. doi: 10.1111/jdi.12828. Epub 2018 Mar 26.
9
Soluble TWEAK and Major Adverse Cardiovascular Events in Patients with CKD.慢性肾脏病患者中可溶性肿瘤坏死因子样弱凋亡诱导因子与主要不良心血管事件
Clin J Am Soc Nephrol. 2016 Mar 7;11(3):413-22. doi: 10.2215/CJN.07900715. Epub 2016 Jan 4.
10
Soluble TWEAK levels predict the presence of carotid atherosclerotic plaques in subjects free from clinical cardiovascular diseases.可溶性肿瘤坏死因子样弱凋亡诱导因子(TWEAK)水平可预测无临床心血管疾病受试者中颈动脉粥样硬化斑块的存在。
Atherosclerosis. 2015 Apr;239(2):358-63. doi: 10.1016/j.atherosclerosis.2015.01.040. Epub 2015 Feb 7.